文献速递胃肠外科

西方人群胃腺癌腹腔镜与开腹次全胃切除术的围术期与5年肿瘤学结局比较

Laparoscopic versus open subtotal gastrectomy for adenocarcinoma of the stomach in a Western population: peri-operative and 5-year oncological outcomes.
PubMed 文献 · Surg Endosc · 2019-10-07

结果显示两组淋巴结清扫数目无差异,LSG术中出血更少但术后出血发生率更高,5年总生存率无显著差异,阳性淋巴结数目是2年总生存的唯一独立危险因素。

要点

  • LSG与OSG在淋巴结清扫数目上无显著差异。
  • LSG术中出血量更少,但术后出血发生率更高。
  • 阳性淋巴结数目是2年总生存的独立预测因素,手术方式不影响生存。

核心结论

  • 在西方胃腺癌患者中,LSG在肿瘤学质量和围术期发病率方面与OSG相当。
  • 2年总生存由阳性淋巴结数目预测,而非手术入路。

研究设计与样本

  • 回顾性、意向性治疗分析研究。
  • 采用单因素分析比较围术期结局,采用逻辑回归结合自举法验证识别预测2年总生存的独立危险因素。

主要发现

  • LSG与OSG的淋巴结清扫数目无差异:36(IQR 24.3-44) vs. 42(IQR 28-59),p=0.165。
  • LSG术中出血量减少:150 ml(IQR 100-250) vs. 553 ml(IQR 338-1075),p<0.001。
  • LSG术后出血发生率增加:3例 vs. 0例,p=0.024。
  • LSG与OSG的5年总生存率分别为63.6%和50%(p=0.372)。
  • 阳性淋巴结数目是2年总生存的唯一显著独立危险因素[OR 0.64(CI 0.47-0.88),p=0.006];术前ASA分级和手术方式不影响2年生存。

临床怎么用

  • 在西方人群中,LSG可作为OSG的替代选择,肿瘤学质量和围术期发病率相当。
  • 需注意LSG术后出血风险较高,围术期应加强监测。
  • 阳性淋巴结数目可用于预测2年总生存,指导术后随访和辅助治疗决策。

局限性

  • 回顾性研究设计。
  • 样本量较小(79例)。
  • 单中心研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study compares the peri-operative and long-term oncological outcomes for laparoscopic subtotal gastrectomy (LSG) versus open subtotal gastrectomy (OSG) for adenocarcinoma of the stomach in a Western population. METHODS: A retrospective, intention-to-treat analysis study was conducted for consecutive patients undergoing gastrectomy with curative intent for adenocarcinoma of the stomach between November 2006 and October 2016. Univariate analysis was used to compare peri-operative outcomes between LSG and OSG. Logistic regression with bootstrapping validation was used to identify independent risk factors for predicting 2-year overall survival. RESULTS: The final analysis included 79 patients. When comparing LSG (n = 30) to OSG (n = 49), there was no difference in the number of resected lymph nodes (36 (IQR 24.3-44) vs. 42 (IQR 28-59), p = 0.165), a reduction in intra-operative blood loss (150 ml (IQR 100-250) vs. 553 ml (IQR 338-1075), p < 0.001) and an increase incidence of post-operative bleeding (3 patients vs. 0, p = 0.024), respectively. Five-year overall survival for LSG (n = 22) versus OSG (n = 20) was 63.6% and 50% (p = 0.372), respectively. The number of positive lymph nodes [OR 0.64 (CI 0.47-0.88), p = 0.006] was the only significant independent risk factor for 2-year overall survival. Pre-operative ASA grading and operative approach did not influence survival outcomes at 2 years. CONCLUSION: This study suggests that LSG is comparable to OSG in Western patients with respect to oncological quality and peri-operative morbidity. Two-year overall survival is predicted by the number of positive lymph nodes and not the operative access employed for resection.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Abbassi-Ghadi N, Durakovic S, Piessen G, et al. Laparoscopic versus open subtotal gastrectomy for adenocarcinoma of the stomach in a Western population: peri-operative and 5-year oncological outcomes. Surg Endosc. 2019. PMID: 31591656. doi:10.1007/s00464-019-07146-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。